Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_assertion type Assertion NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_head.
- NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_assertion wasGeneratedBy ECO_0000203 NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_provenance.
- NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_assertion wasDerivedFrom befree-20140225 NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_provenance.
- NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_assertion SIO_000772 16290123 NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_provenance.
- NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_assertion evidence source_evidence_literature NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_provenance.
- NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_assertion description "[Patients with type 2 diabetes without proteinuria, were treated with RAS inhibitors, the first being an ACE inhibitor (ACEI) and the second, an angiotensin II (ATII) receptor blocker (ARB) for 8 weeks each.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640049.RAXzfyPNadwHn6p9jJrGHZxfTrDzNQpqBvNDQdrPcFqE4130_provenance.